Literature DB >> 28972165

Surfactant protein A down-regulates epidermal growth factor receptor by mechanisms different from those of surfactant protein D.

Yoshihiro Hasegawa1,2, Motoko Takahashi3, Shigeru Ariki3, Atsushi Saito3,2, Yasuaki Uehara3,2, Rina Takamiya3, Koji Kuronuma2, Hirofumi Chiba2, Yuji Sakuma4, Hiroki Takahashi2, Yoshio Kuroki3.   

Abstract

We recently reported that the lectin surfactant protein D (SP-D) suppresses epidermal growth factor receptor (EGFR) signaling by interfering with ligand binding to EGFR through an interaction between the carbohydrate-recognition domain (CRD) of SP-D and N-glycans of EGFR. Here, we report that surfactant protein A (SP-A) also suppresses EGF signaling in A549 human lung adenocarcinoma cells and in CHOK1 cells stably expressing human EGFR and that SP-A inhibits the proliferation and motility of the A549 cells. Results with 125I-EGF indicated that SP-A interferes with EGF binding to EGFR, and a ligand blot analysis suggested that SP-A binds EGFR in A549 cells. We also found that SP-A directly binds the recombinant extracellular domain of EGFR (soluble EGFR or sEGFR), and this binding, unlike that of SP-D, was not blocked by EDTA, excess mannose, or peptide:N-glycosidase F treatment. We prepared a collagenase-resistant fragment (CRF) of SP-A, consisting of CRD plus the neck domain of SP-A, and observed that CRF directly binds sEGFR but does not suppress EGF-induced phosphorylation of EGFR in or proliferation of A549 cells. These results indicated that SP-A binds EGFR and down-regulates EGF signaling by inhibiting ligand binding to EGFR as well as SP-D. However, unlike for SP-D, SP-A lectin activity and EGFR N-glycans were not involved in the interaction between SP-A and EGFR. Furthermore, our results suggested that oligomerization of SP-A is necessary to suppress the effects of SP-A on EGF signaling.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  collectin; epidermal growth factor receptor (EGFR); lung cancer; oligomerization; pulmonary surfactant

Mesh:

Substances:

Year:  2017        PMID: 28972165      PMCID: PMC5682966          DOI: 10.1074/jbc.M117.800771

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Immunohistochemical localization of pulmonary surfactant apoproteins in various lung tumors. Special reference to nonmucus producing lung adenocarcinomas.

Authors:  Y Mizutani; T Nakajima; S Morinaga; M Gotoh; Y Shimosato; T Akino; A Suzuki
Journal:  Cancer       Date:  1988-02-01       Impact factor: 6.860

2.  Surfactant protein D suppresses lung cancer progression by downregulation of epidermal growth factor signaling.

Authors:  Y Hasegawa; M Takahashi; S Ariki; D Asakawa; M Tajiri; Y Wada; Y Yamaguchi; C Nishitani; R Takamiya; A Saito; Y Uehara; J Hashimoto; Y Kurimura; H Takahashi; Y Kuroki
Journal:  Oncogene       Date:  2014-03-10       Impact factor: 9.867

3.  A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D.

Authors:  Rikke Leth-Larsen; Peter Garred; Henriette Jensenius; Joseph Meschi; Kevan Hartshorn; Jens Madsen; Ida Tornoe; Hans O Madsen; Grith Sørensen; Erika Crouch; Uffe Holmskov
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

Review 4.  In defense of the lung: surfactant protein A and surfactant protein D.

Authors:  Paul S Kingma; Jeffrey A Whitsett
Journal:  Curr Opin Pharmacol       Date:  2006-03-30       Impact factor: 5.547

5.  Protein 1 and Clara cell 10-kDa protein distribution in normal and neoplastic tissues with emphasis on the respiratory system.

Authors:  H Nomori; S Morinaga; R Kobayashi; C Torikata
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

6.  Pulmonary collectins protect macrophages against pore-forming activity of Legionella pneumophila and suppress its intracellular growth.

Authors:  Kaku Sawada; Shigeru Ariki; Takashi Kojima; Atsushi Saito; Masami Yamazoe; Chiaki Nishitani; Takeyuki Shimizu; Motoko Takahashi; Hiroaki Mitsuzawa; Shin-Ichi Yokota; Norimasa Sawada; Nobuhiro Fujii; Hiroki Takahashi; Yoshio Kuroki
Journal:  J Biol Chem       Date:  2010-01-07       Impact factor: 5.157

7.  Identification of CD245 as myosin 18A, a receptor for surfactant A: A novel pathway for activating human NK lymphocytes.

Authors:  A De Masson; J Giustiniani; A Marie-Cardine; J D Bouaziz; N Dulphy; D Gossot; P Validire; A Tazi; C Garbar; M Bagot; Y Merrouche; A Bensussan
Journal:  Oncoimmunology       Date:  2016-01-13       Impact factor: 8.110

8.  Disease-associated mutations in human mannose-binding lectin compromise oligomerization and activity of the final protein.

Authors:  Flemming Larsen; Hans O Madsen; Robert B Sim; Claus Koch; Peter Garred
Journal:  J Biol Chem       Date:  2004-02-05       Impact factor: 5.157

Review 9.  An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors.

Authors:  Antony W Burgess; Hyun-Soo Cho; Charles Eigenbrot; Kathryn M Ferguson; Thomas P J Garrett; Daniel J Leahy; Mark A Lemmon; Mark X Sliwkowski; Colin W Ward; Shigeyuki Yokoyama
Journal:  Mol Cell       Date:  2003-09       Impact factor: 17.970

10.  Surfactant protein a in cystic fibrosis: supratrimeric structure and pulmonary outcome.

Authors:  Matthias Griese; Stephanie Heinrich; Felix Ratjen; Michael Kabesch; Karl Paul; Manfred Ballmann; Ernst Rietschel; Matthias Kappler
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

View more
  5 in total

1.  Role of Surfactant Protein D in Experimental Otitis Media.

Authors:  Osama Abdel-Razek; Tianyi Liu; Xinghua Chen; Qiushi Wang; Gautam Vanga; Guirong Wang
Journal:  J Innate Immun       Date:  2021-02-08       Impact factor: 7.349

Review 2.  Characteristics of surfactant proteins in tumorigenic and inflammatory lung lesions in rodents.

Authors:  Masanao Yokohira; Keiko Yamakawa; Yuko Nakano-Narusawa; Nozomi Hashimoto; Shohei Kanie; Shota Yoshida; Katsumi Imaida
Journal:  J Toxicol Pathol       Date:  2018-06-02       Impact factor: 1.628

3.  Use of four genes in exosomes as biomarkers for the identification of lung adenocarcinoma and lung squamous cell carcinoma.

Authors:  Bingji Cao; Pengyu Wang; Lina Gu; Junfeng Liu
Journal:  Oncol Lett       Date:  2021-02-03       Impact factor: 2.967

4.  Establishment and validation of nomogram for predicting immuno checkpoint inhibitor related pneumonia.

Authors:  Xiaoqi Li; Fei Lv; Ying Wang; Zhenguang Du
Journal:  BMC Pulm Med       Date:  2022-09-01       Impact factor: 3.320

5.  Pulmonary-Affinity Paclitaxel Polymer Micelles in Response to Biological Functions of Ambroxol Enhance Therapeutic Effect on Lung Cancer.

Authors:  Wenxiu He; Wenze Xiao; Xiulei Zhang; Yali Sun; Yiting Chen; Qinyue Chen; Xiaoling Fang; Shilin Du; Xianyi Sha
Journal:  Int J Nanomedicine       Date:  2020-02-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.